BIO5 member Vlad Kalinichenko is helping lead the new Phoenix Children’s Research Institute, a partnership between the University of Arizona College of Medicine – Phoenix and Phoenix Children’s. His team’s work focuses on developing innovative nanoparticle-based treatments for lung diseases in premature infants, supported by major NIH grants, as part of a broader effort to improve pediatric health and advance research statewide.